{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:25:10Z","timestamp":1790324710505,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,8,21]],"date-time":"2004-08-21T00:00:00Z","timestamp":1093046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/s00125-004-1477-5","type":"journal-article","created":{"date-parts":[[2004,8,20]],"date-time":"2004-08-20T10:28:03Z","timestamp":1092997683000},"page":"1488-1492","source":"Crossref","is-referenced-by-count":84,"title":["Vascular calcification and osteolysis in diabetic neuropathy?is RANK-L the missing link?"],"prefix":"10.1007","volume":"47","author":[{"given":"W.","family":"Jeffcoate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,8,21]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/bmj.284.6320.928","volume":"284","author":"Edmonds","year":"1982","unstructured":"Edmonds ME, Morrison N, Laws JW, Watkins PJ (1982) Medial arterial calcification and diabetic neuropathy. BMJ 284:928?930","journal-title":"BMJ"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00251822","volume":"24","author":"Goebel","year":"1983","unstructured":"Goebel FD, Fuessl HS (1983) Monckeberg?s sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 24:347?350","journal-title":"Diabetologia"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF00279614","volume":"30","author":"Corbin","year":"1987","unstructured":"Corbin DO, Young RJ, Morrison DC et al. (1987) Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia 30:468?473","journal-title":"Diabetologia"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1056-8727(01)00178-7","volume":"16","author":"Mayfield","year":"2002","unstructured":"Mayfield JA, Caps MT, Boyko EJ, Ahroni JH, Smith DG (2002) Relationship of medial arterial calcinosis to autonomic neuropathy and adverse outcomes in a diabetic veteran population. J Diabet Complications 16:165?171","journal-title":"J Diabet Complications"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11892-003-0049-2","volume":"3","author":"Chen","year":"2003","unstructured":"Chen NX, Moe SM (2003) Arterial calcification in diabetes. Curr Diab Rep 3:28?32","journal-title":"Curr Diab Rep"},{"key":"CR6","first-page":"282","volume":"17","author":"Mozes","year":"1998","unstructured":"Mozes G, Keresztury G, Kadar A et al. (1998) Atherosclerosis in amputated legs of patients with and without diabetes mellitus. Int Angiol 17:282?286","journal-title":"Int Angiol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/cs1010261","volume":"101","author":"Carrington","year":"2001","unstructured":"Carrington AL, Abbott CA, Griffiths J et al. (2001) Peripheral vascular and nerve function associated with lower limb amputation in people with and without diabetes. Clin Sci 101:261?266","journal-title":"Clin Sci"},{"key":"CR8","doi-asserted-by":"crossref","unstructured":"Sinha S, Munichoodappa C, Kozak GP (1972) Neuro-arthropathy (Charcot joints) in diabetes mellitus: a clinical study of 101 cases. Medicine (Baltimore) 51:191?210","DOI":"10.1097\/00005792-197205000-00006"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2214\/ajr.121.1.22","volume":"121","author":"Clouse","year":"1974","unstructured":"Clouse ME, Gramm HF, Legg M, Flood T (1974) Diabetic osteoarthropathy: clinical and roentgenographic observations in 90 cases. Am J Roentgenol 121:22?34","journal-title":"Am J Roentgenol"},{"key":"CR10","first-page":"90","volume":"26","author":"Ziegler","year":"1992","unstructured":"Ziegler R (1992) Diabetes mellitus and bone metabolism. Horm Metab Res Suppl 26:90?94","journal-title":"Horm Metab Res Suppl"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1464-5491.1985.tb00683.x","volume":"2","author":"Cundy","year":"1985","unstructured":"Cundy T, Edmonds ME, Watkins PJ (1985) Osteopaenia and metatarsal fractures in diabetic neuropathy. Diabet Med 2:461?464","journal-title":"Diabet Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/1056-8727(94)90058-2","volume":"8","author":"Kayath","year":"1994","unstructured":"Kayath MJ, Dib SA, Vieia JG (1994) Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabet Complications 8:97?104","journal-title":"J Diabet Complications"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1464-5491.1995.tb00389.x","volume":"12","author":"Forst","year":"1995","unstructured":"Forst T, Pfutzner A, Kann P et al. (1995) Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet Med 12:874?879","journal-title":"Diabet Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2337\/diacare.22.5.827","volume":"22","author":"Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P (1999) Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 22:827?831","journal-title":"Diabetes Care"},{"key":"CR15","first-page":"843","volume":"57","author":"Edmonds","year":"1985","unstructured":"Edmonds ME, Clarke MB, Newton S, Barrett J, Watkins PJ (1985) Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med 57:843?855","journal-title":"Q J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1464-5491.2000.00233.x","volume":"17","author":"Jeffcoate","year":"2000","unstructured":"Jeffcoate W, Lima J, Nobrega L (2000) The Charcot foot. Diabet Med 17:1?6","journal-title":"Diabet Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00125-002-0885-7","volume":"45","author":"Rajbhandari","year":"2002","unstructured":"Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S (2002) Charcot neuroarthropathy in diabetes mellitus. Diabetologia 45:1085?1096","journal-title":"Diabetologia"},{"key":"CR18","first-page":"2355","volume":"85","author":"Hofbauer","year":"2000","unstructured":"Hofbauer LC, Heufelder AE (2000) The role of receptor activator of nuclear factor-?B ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocrinol Metab 85:2355?2363","journal-title":"J Clin Endocrinol Metab"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"Khosla","year":"2001","unstructured":"Khosla S (2001) Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142:5050?5055","journal-title":"Endocrinology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","volume":"22","author":"Schoppet","year":"2002","unstructured":"Schoppet M, Preissner KT, Hofbauer LC (2002) RANK ligand and osteoprotegerin. Paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 22:549?553","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1470-2045(03)01076-3","volume":"4","author":"Ashcroft","year":"2003","unstructured":"Ashcroft AJ, Davies FE, Morgan GJ (2003) Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. Lancet Oncol 4:284?292","journal-title":"Lancet Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/bbrc.2000.3953","volume":"279","author":"Mancini","year":"2000","unstructured":"Mancini L, Moradi-Bidhendi N, Brandi ML, Perretti M, MacIntyre I (2000) Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. Biochem Biophys Res Comm 279:391?397","journal-title":"Biochem Biophys Res Comm"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S8756-3282(01)00494-X","volume":"29","author":"Cornish","year":"2001","unstructured":"Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29:162?168","journal-title":"Bone"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jemt.10119","volume":"58","author":"Imai","year":"2002","unstructured":"Imai S, Matsusue Y (2002) Neuronal regulation of bone metabolism and anabolism: calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc Res Tech 58:61?69","journal-title":"Microsc Res Tech"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(01)05494-0","volume":"358","author":"Hofbauer","year":"2001","unstructured":"Hofbauer LC, Schoppet M (2001) Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358:257?259","journal-title":"Lancet"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/000456320203900602","volume":"39","author":"Buckley","year":"2002","unstructured":"Buckley KA, Fraser WD (2002) Receptor activator for nuclear factor kappaB ligand and osteoprotegerin: regulators of bone physiology and immune responses\/potential therapeutic agents and biochemical markers. Ann Clin Biochem 39:551?556","journal-title":"Ann Clin Biochem"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","volume":"88","author":"Schoppet","year":"2003","unstructured":"Schoppet M, Sattler ANM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC (2003) Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 88:1024?1028","journal-title":"J Clin Endocrinol Metab"},{"key":"CR28","first-page":"631","volume":"86","author":"Browner","year":"2001","unstructured":"Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631?637","journal-title":"J Clin Endocrinol Metab"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/eje.0.1490039","volume":"149","author":"Knudsen","year":"2003","unstructured":"Knudsen ST, Foss CH, Poulsen PL, Andersen NH, Mogensen CE, Rasmussen LM (2003) Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. Eur J Endocrinol 149:39?42","journal-title":"Eur J Endocrinol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00041552-200207000-00011","volume":"11","author":"Demer","year":"2002","unstructured":"Demer LL, Tintut Y, Parhami F (2002) Novel mechanisms in accelerated vascular calcification in renal disease patients. Curr Opin Nephrol Hypertens 11:437?443","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcp.10270","volume":"196","author":"Kanatani","year":"2003","unstructured":"Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K (2003) Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. J Cell Physiol 196:180?189","journal-title":"J Cell Physiol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(03)00655-3","volume":"42","author":"Nitta","year":"2003","unstructured":"Nitta K, Akiba T, Uchida K et al. (2003) The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 42:303?309","journal-title":"Am J Kidney Dis"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jemt.10370","volume":"61","author":"Sasaki","year":"2003","unstructured":"Sasaki T (2003) Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption. Microsc Res Tech 61:483?495","journal-title":"Microsc Res Tech"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1359\/jbmr.2001.16.6.1004","volume":"16","author":"Kon","year":"2001","unstructured":"Kon T, Cho TJ, Aizawa T et al. (2001) Expression of osteoprotegerin, receptor activator of NF-kappa ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004?1014","journal-title":"J Bone Miner Res"},{"key":"CR35","unstructured":"Knaggs RI (1926) Charcot joints. In: Knaggs RI (ed.) Inflammatory and toxic disorders of bone. John Wright, Bristol, pp\u00a0105?119"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/archinte.1987.00370080142027","volume":"147","author":"Edelman","year":"1987","unstructured":"Edelman SV, Kosofsky EM, Paul RA, Kozak GP (1987) Neuro-arthropathy (Charcot?s joint) in diabetes mellitus following revascularisation surgery. Arch Intern Med 147:1504?1508","journal-title":"Arch Intern Med"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-5491.1994.tb00225.x","volume":"11","author":"Selby","year":"1994","unstructured":"Selby PL, Young MJ, Bouton AJM (1994) Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 11:28?31","journal-title":"Diabet Med"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","volume":"44","author":"Jude","year":"2001","unstructured":"Jude EB, Selby PL, Burgess J et al. (2001) Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 44:2032?2037","journal-title":"Diabetologia"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-003-0085-6","volume":"51","author":"Reszka","year":"2003","unstructured":"Reszka AA, Rodan GA (2003) Bisphosphonate mechanism of action. Curr Rheumatol Rep 51:65?74","journal-title":"Curr Rheumatol Rep"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","volume":"9","author":"Rogers","year":"2003","unstructured":"Rogers MJ (2003) New insights into the mechanism of action of bisphosphonates. Curr Pharm Des 9:2643?2658","journal-title":"Curr Pharm Des"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ard.54.8.687-a","volume":"54","author":"Maillefert","year":"1995","unstructured":"Maillefert JF, Chatard C, Owen S, Peere T, Taverner C, Tebib J (1995) Treatment of refractory reflex sympathetic dystrophy with pamidronate. Ann Rheum Dis 54:687","journal-title":"Ann Rheum Dis"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02238763","volume":"16","author":"Cortet","year":"1997","unstructured":"Cortet B, Flipo R-M, Coquerelle P, Duquesnoy B, Delcambre B (1997) Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of the efficacy and safety of second generation bisphosphonate pamidronate. Clin Rheumatol 16:51?56","journal-title":"Clin Rheumatol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00223-001-2128-1","volume":"71","author":"Kudo","year":"2002","unstructured":"Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanason NA (2002) Isolation of human osteoclasts formed in vitro: hormonal effects on bone-resorbing activity of human osteoclasts. Calcif Tissue Int 71:539?546","journal-title":"Calcif Tissue Int"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1359\/jbmr.2002.17.7.1171","volume":"17","author":"Price","year":"2002","unstructured":"Price PA, Caputo JM, Williamson MK (2002) Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodelling compartment. J Bone Miner Res 17:1171?1179","journal-title":"J Bone Miner Res"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s001250051062","volume":"41","author":"Forsblom","year":"1998","unstructured":"Forsblom CM, Sane T, Group PH et al. (1998) Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41:1253?1262","journal-title":"Diabetologia"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/diacare.26.6.1895","volume":"26","author":"Maser","year":"2003","unstructured":"Maser RE, Mitchell BD, Vinik AI, Freeman R (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 26:1895?1901","journal-title":"Diabetes Care"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.287.12.1548","volume":"287","author":"Klassen","year":"2002","unstructured":"Klassen PS, Lowrie EG, Reddan DN et al. (2002) Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287:1548?1555","journal-title":"JAMA"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1523-1755.2002.00173.x","volume":"61","author":"Tozawa","year":"2002","unstructured":"Tozawa M, Iseki K, Iseki C et al. (2002) Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 61:717?726","journal-title":"Kidney Int"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-004-1477-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-004-1477-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-004-1477-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:44:29Z","timestamp":1558611869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-004-1477-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,21]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1007\/s00125-004-1477-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,21]]}}}